NOTCH1 Drives Sexually Dimorphic Immune Responses in Hepatocellular Carcinoma

0
23
The authors demonstrated that NOTCH1, an understudied oncogene in hepatocellular carcinoma, elicits sexually dimorphic anti-tumor immunity and response to FDA-approved immunotherapies.
[Cancer Discovery]
Abstract